FNY Investment Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-190
Closed -$7K 649
2022
Q2
$7K Buy
+190
New +$9.23K 0.01% 451
2021
Q4
Sell
-100
Closed -$6K 553
2021
Q3
$6K Buy
100
+50
+100% +$2.93K ﹤0.01% 573
2021
Q2
$2K Buy
+50
New +$2.5K ﹤0.01% 681

Other funds holding ATEX

FNY Investment Advisers's ATEX Position: Q2 2026 in Review

FNY Investment Advisers reduced its Anterix (ATEX) stake by 97% in Q2 2026, selling an estimated $638K and leaving 350 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #462.

FNY Investment Advisers first reported a position in ATEX in Q2 2018 and has held it in 15 quarters since. The position peaked at $428K in Q1 2026. 59 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • FNY Investment Advisers held 350 shares of Anterix worth $36K as of Q2 2026.
  • FNY Investment Advisers sold 10,871 Anterix shares in Q2 2026, an estimated $638K.
  • Anterix made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #462 holding.
  • FNY Investment Advisers first reported a position in Anterix in Q2 2018 and has held it in 15 quarters since.
  • FNY Investment Advisers's Anterix position peaked at $428K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.